PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 10:05 AM ET

Sponsor Check › Person

RD
No photo found yet (own website and image search run after this page is viewed)

Ryan Drant

Named as an officer, director or promoter on SEC Form D filings · MD, CA, MA, TN, GA, CO · May 27, 2009 → Apr 16, 2026

38deals (issuers)
$7.31Breported sold
2,158investors
118Form D filings
2009–2026years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:18 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Ryan Drant is listed as an executive officer and director on 118 SEC Form D filings by 38 issuers between Apr 2009 and Apr 2026. Largest by amount reported sold: NEW ENTERPRISE ASSOCIATES 13 LP (Baltimore, MD — pooled investment fund — 2009; $2.46B reported sold to 187 investors), New Enterprise Associates 14, L.P. (Timonium, MD — pooled investment fund — 2012; $2.08B reported sold to 146 investors), Radiology Partners Holdings, LLC (Nashville, TN — other health care — 2014–2017; $719.8M reported sold to 645 investors), Questa Capital Partners III, L.P. (San Francisco, CA — pooled investment fund — 2022–2023; $396.6M reported sold to 67 investors), Questa Capital Partners II, L.P. (San Francisco, CA — pooled investment fund — 2020; $304.9M reported sold to 59 investors) and 33 more (all listed below).

What this means That is a lot of deals — 38 separate companies raised money with this person listed as executive officer and director, over about 17 years. Across those companies the filings report $7.31B sold in total.

Listed alongside Joshua Makower (25 shared filings), Robert W. Croce (18 shared filings), Gregory Lambrecht (17 shared filings), John Nehra (13 shared filings), Robert More (13 shared filings) and 258 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Ryan. Each name links to their own page.

The issuers belong to 4 sponsor groups: Questa (5 issuers, $884M reported sold, 2016–2023), Nea (19 issuers, $10.96B reported sold, 2009–2025), Carticept (2 issuers, $16.6M reported sold, 2010–2016) and Exploramed (3 issuers, $65.4M reported sold, 2011–2021).

What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared the newest 50 of 118 public filings for Ryan Drant and found 10 differences, 1 worth asking the sponsor about: 8 Form Ds were filed more than 15 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Ryan Drant has not run yet — it is #18,099 of 46,814 in line; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:18 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Ryan Drant..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:18 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

10 differences found between the filings for Ryan Drant — 1 worth asking about (compared the newest 50 of 118 filings on Oct 24, 2026; older filings not covered)

Note · May 4, 2012 – Aug 17, 2012

Bankruptcy case: Christopher Shen and Yihsuan Ho — filed May 4, 2012

United States Bankruptcy Court, C.D. California docket "Christopher Shen and Yihsuan Ho" filed May 4, 2012, closed Aug 17, 2012. Christopher Shen (listed on the same filings) is listed as Debtor ("Christopher Shen and Yihsuan Ho"). Our match estimate: 70%.

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, C.D. California ↗Christopher Shen — PartnerFacts page ↗
Sources
Note · Jul 8, 2002 – Oct 23, 2002

Bankruptcy case: Monogram Credit Card Bank Of Georgia v. Salkeld — filed Jul 8, 2002

United States Bankruptcy Court, E.D. California docket "Monogram Credit Card Bank Of Georgia v. Salkeld" filed Jul 8, 2002, closed Oct 23, 2002. Matthew Salkeld (listed on the same filings) is listed as Defendant ("Salkeld"). Our match estimate: 70%.

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, E.D. California ↗Matthew Salkeld — PartnerFacts page ↗
Sources
Note · May 23, 1994 – Nov 21, 1994

Bankruptcy case: Salkeld v. Landmark Bank — filed May 23, 1994

United States Bankruptcy Court, C.D. California docket "Salkeld v. Landmark Bank" filed May 23, 1994, closed Nov 21, 1994. Matthew Salkeld (listed on the same filings) is listed as Plaintiff ("Salkeld"). Our match estimate: 70%.

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, C.D. California ↗Matthew Salkeld — PartnerFacts page ↗
Sources
Note · Sep 15, 2017 – Jun 14, 2022

Ryan Drant appears on 2 deals that stopped filing before reaching their target

Questa Capital Opportunities II, L.P. (last filing Jun 14, 2022; $0 sold of $125,000,000); Questa Capital Partners I, L.P. (last filing Sep 15, 2017; $99,747,475 sold of $250,000,000). Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

Questa Capital Opportunities II, L.P. — PartnerFacts page ↗Questa Capital Partners I, L.P. — PartnerFacts page ↗
Sources
Worth asking · Mar 15, 2017 – Dec 30, 2024

8 Form Ds were filed more than 15 days after the first sale

Form D filed 83 days after the first sale — DispatchHealth Holdings, Inc. · Form D filed 17 days after the first sale — Aerin Medical Inc. · Form D filed 35 days after the first sale — INTRINSIC THERAPEUTICS INC · Form D filed 34 days after the first sale — Eximis Surgical Inc. · Form D filed 28 days after the first sale — DispatchHealth Holdings, Inc. · and 3 more

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Jun 24, 2020 ↗DispatchHealth Holdings, Inc. — PartnerFacts page ↗Form D · Dec 30, 2024 ↗Aerin Medical Inc. — PartnerFacts page ↗
Sources
Note · Jun 7, 2016 – Dec 30, 2024

29 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Aerin Medical Inc. (latest filing Dec 30, 2024) · No amendment in the last 12 months on an offering that may still be open — Calyxo, Inc. (latest filing Dec 26, 2024) · No amendment in the last 12 months on an offering that may still be open — Eximis Surgical Inc. (latest filing May 10, 2024) · No amendment in the last 12 months on an offering that may still be open — INTRINSIC THERAPEUTICS INC (latest filing Dec 8, 2023) · No amendment in the last 12 months on an offering that may still be open — CORTICA INC. (latest filing Apr 25, 2023) · and 24 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Dec 30, 2024 ↗Aerin Medical Inc. — PartnerFacts page ↗Form D · Dec 26, 2024 ↗Calyxo, Inc. — PartnerFacts page ↗
Sources
Note · Jun 15, 2016 – May 10, 2024

8 offerings changed their target amount between filings

Offering amount changed between filings — Eximis Surgical Inc. · Offering amount changed between filings — Avive Solutions, Inc. · Offering amount changed between filings — CORTICA INC. · Offering amount lowered between filings — Questa Capital Partners III, L.P. · Offering amount changed between filings — Questa Capital Partners II, L.P. · and 3 more

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Form D (earlier) · Apr 24, 2023 ↗Form D/A (later) · May 10, 2024 ↗Eximis Surgical Inc. — PartnerFacts page ↗Form D (earlier) · Feb 14, 2024 ↗
Sources
Note · Jun 14, 2022 – Jun 13, 2023

Minimum investment changed between filings — Questa Capital Partners III, L.P.

The Jun 14, 2022 filing lists a minimum of $0; the Jun 13, 2023 Form D/A lists $50,000.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Jun 14, 2022 ↗Form D/A (later) · Jun 13, 2023 ↗Questa Capital Partners III, L.P. — PartnerFacts page ↗
Sources
Note · Oct 2, 2019 – Feb 14, 2024

4 address changes between filings

Address moved from San Francisco, CA to Brisbane, CA — Avive Solutions, Inc. · Address moved from Norcross, GA to Peachtree Corners, GA — ControlRad, Inc. · Address moved from San Diego, CA to Pleasanton, CA — Calyxo, Inc. · Address moved from Peachtree Corners, GA to Norcross, GA — ControlRad, Inc.

What this means Businesses move. If you were told one city and the forms say another, ask which is current.

Form D · Mar 11, 2022 ↗Form D · Feb 14, 2024 ↗Avive Solutions, Inc. — PartnerFacts page ↗Form D · Sep 25, 2020 ↗
Sources
Note · Jun 15, 2016 – Apr 16, 2026

Ryan Drant is listed with 5 different address states: CA, MA, CO, MD, GA

CA on 28 filings (Jun 15, 2016 to Apr 16, 2026); MA on 10 filings (Dec 16, 2016 to Dec 8, 2023); CO on 11 filings (Apr 3, 2017 to May 10, 2024); MD on 1 filing (Jul 27, 2018); GA on 3 filings (Oct 2, 2019 to Apr 11, 2022).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Jun 15, 2016 ↗Form D · Dec 16, 2016 ↗Form D · Apr 3, 2017 ↗Form D · Jul 27, 2018 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. We compared the newest 50 of 118 filings (work cap); older filings are not covered here. As of Oct 24, 2026.

5. Money to insiders

2 of 93 offerings report sales commissions totalling $1,432,500; 1 reports finder's fees totalling $680; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Apr 16, 2026 D
Calyxo, Inc.
File 021-580717
$0$0$0None listed on this filingEDGAR ↗
Dec 30, 2024 D
Aerin Medical Inc.
File 021-533543
$0$0$0None listed on this filingEDGAR ↗
Dec 26, 2024 D
Calyxo, Inc.
File 021-533311
$0$0$0None listed on this filingEDGAR ↗
Nov 22, 2024 D
CORTICA INC.
File 021-530275
$0$0$0None listed on this filingEDGAR ↗
May 10, 2024 D/A
Eximis Surgical Inc.
File 021-479792
$0$0$0None listed on this filingEDGAR ↗
Apr 18, 2024 D/A
Avive Solutions, Inc.
File 021-505338
$0$0$0None listed on this filingEDGAR ↗
Dec 8, 2023 D
INTRINSIC THERAPEUTICS INC
File 021-499150
$0$0$0None listed on this filingEDGAR ↗
Nov 3, 2023 D
Calyxo, Inc.
File 021-496425
$0$0$0None listed on this filingEDGAR ↗
Oct 2, 2023 D/A
CORTICA INC.
File 021-479914
$0$0$0None listed on this filingEDGAR ↗
Aug 18, 2023 D
INTRINSIC THERAPEUTICS INC
File 021-490159
$0$0$0None listed on this filingEDGAR ↗
Jun 13, 2023 D/A
Questa Capital Partners III, L.P.
File 021-449140
$0$0$0None listed on this filingEDGAR ↗
Apr 25, 2023 D
CORTICA INC.
File 021-479915
$0$0$0None listed on this filingEDGAR ↗
Apr 13, 2023 D
INTRINSIC THERAPEUTICS INC
File 021-478810
$0$0$0None listed on this filingEDGAR ↗
Nov 28, 2022 D
DispatchHealth Holdings, Inc.
File 021-465944
$0$0$0None listed on this filingEDGAR ↗
Jun 14, 2022 D
Questa Capital Opportunities II, L.P.
File 021-449142
$0$0$0None listed on this filingEDGAR ↗
May 23, 2022 D
Bicycle Health Inc.
File 021-446547
$0$0$0None listed on this filingEDGAR ↗
May 4, 2022 D
Aerin Medical Inc.
File 021-444391
$0$0$0None listed on this filingEDGAR ↗
Apr 11, 2022 D
ControlRad, Inc.
File 021-441195
$0$0$0None listed on this filingEDGAR ↗
Mar 11, 2022 D
Avive Solutions, Inc.
File 021-436917
$0$0$0None listed on this filingEDGAR ↗
Feb 2, 2022 D
Calyxo, Inc.
File 021-431891
$0$0$0None listed on this filingEDGAR ↗
Jun 14, 2021 D
Bicycle Health Inc.
File 021-402931
$0$0$0None listed on this filingEDGAR ↗
Apr 7, 2021 D
INTRINSIC THERAPEUTICS INC
File 021-394982
$0$0$0None listed on this filingEDGAR ↗
Mar 25, 2021 D
Questa Capital Opportunities I, L.P.
File 021-393548
$0$0$0None listed on this filingEDGAR ↗
Mar 3, 2021 D
DispatchHealth Holdings, Inc.
File 021-391097
$0$0$0None listed on this filingEDGAR ↗
Sep 25, 2020 D
ControlRad, Inc.
File 021-376403
$0$0$0None listed on this filingEDGAR ↗
Aug 21, 2020 D/A
Questa Capital Partners II, L.P.
File 021-358721
$0 (est.)$0 (est.)$0Acalyx Advisors, Inc. BrokerCheck CRD 174667 ↗EDGAR ↗
Jun 24, 2020 D
DispatchHealth Holdings, Inc.
File 021-369578
$0$0$0None listed on this filingEDGAR ↗
Feb 28, 2020 D/A
Eximis Surgical Inc.
File 021-325404
$0$0$0None listed on this filingEDGAR ↗
Oct 15, 2019 D
Calyxo, Inc.
File 021-351025
$0$0$0None listed on this filingEDGAR ↗
Oct 2, 2019 D
ControlRad, Inc.
File 021-350166
$0$0$0None listed on this filingEDGAR ↗
May 8, 2019 D
DispatchHealth Holdings, Inc.
File 021-339146
$0$0$0None listed on this filingEDGAR ↗
Apr 23, 2019 D
INTRINSIC THERAPEUTICS INC
File 021-337885
$0$0$0None listed on this filingEDGAR ↗
Feb 11, 2019 D
Solace Therapeutics Inc
File 021-332570
$0$0$0None listed on this filingEDGAR ↗
Oct 19, 2018 D
SyncHR, Inc.
File 021-323961
$0$0$0None listed on this filingEDGAR ↗
Jul 27, 2018 D
SPINE WAVE, INC
File 021-317961
$0$0$0None listed on this filingEDGAR ↗
May 21, 2018 D
SyncHR, Inc.
File 021-312891
$0$0$0None listed on this filingEDGAR ↗
Sep 15, 2017 D/A
Questa Capital Partners I, L.P.
File 021-273031
$0 (est.)$0 (est.)$0Acalyx Advisors Inc. BrokerCheck CRD 174667 ↗EDGAR ↗
May 26, 2017 D
Medrio, Inc.
File 021-287590
$0$0$0None listed on this filingEDGAR ↗
May 25, 2017 D/A
Earlens Corp
File 021-265112
$0$0$0None listed on this filingEDGAR ↗
May 16, 2017 D
Radiology Partners Holdings, LLC
File 021-286855
$0$0$0None listed on this filingEDGAR ↗
May 8, 2017 D
ADVANCED CARDIAC THERAPEUTICS INC
File 021-286216
$0$0$0None listed on this filingEDGAR ↗
Apr 3, 2017 D
SyncHR, Inc.
File 021-283926
$0$0$0None listed on this filingEDGAR ↗
Mar 31, 2017 D
Moximed, Inc
File 021-283747
$0$0$0None listed on this filingEDGAR ↗
Mar 21, 2017 D/A
INTRINSIC THERAPEUTICS INC
File 021-276448
$0$0$0None listed on this filingEDGAR ↗
Jan 11, 2017 D
Radiology Partners Holdings, LLC
File 021-278094
$0$0$0None listed on this filingEDGAR ↗
Jan 6, 2017 D
NEOTRACT INC
File 021-277831
$0$0$0None listed on this filingEDGAR ↗
Nov 18, 2016 D
Cartiva, Inc.
File 021-274816
$0$0$0None listed on this filingEDGAR ↗
Sep 6, 2016 D
Solace Therapeutics Inc
File 021-270110
$0$0$0None listed on this filingEDGAR ↗
May 31, 2016 D
SPINE WAVE, INC
File 021-264099
$0$0$0None listed on this filingEDGAR ↗
Oct 13, 2015 D
SyncHR, Inc.
File 021-249189
$0$0$0None listed on this filingEDGAR ↗
Aug 21, 2015 D
TriVascular Technologies, Inc.
File 021-246251
$0$0$0None listed on this filingEDGAR ↗
May 5, 2015 D
Moximed, Inc
File 021-239193
$0$0$0None listed on this filingEDGAR ↗
Apr 20, 2015 D
Nuelle, Inc.
File 021-238282
$0$0$0None listed on this filingEDGAR ↗
Apr 17, 2015 D
Cartiva, Inc.
File 021-238181
$0$0$0None listed on this filingEDGAR ↗
Mar 9, 2015 D/A
Willow Innovations, Inc.
File 021-232596
$0$0$0None listed on this filingEDGAR ↗
Dec 29, 2014 D
Cartiva, Inc.
File 021-230975
$0$0$0None listed on this filingEDGAR ↗
Sep 17, 2014 D
INTRINSIC THERAPEUTICS INC
File 021-224858
$0$0$0None listed on this filingEDGAR ↗
Jul 8, 2014 D/A
Nuelle, Inc.
File 021-210421
$0$0$0None listed on this filingEDGAR ↗
May 22, 2014 D
Radiology Partners Holdings, LLC
File 021-217868
$0$0$0None listed on this filingEDGAR ↗
Jan 28, 2014 D/A
NEOTRACT INC
File 021-178788
$0$0$0None listed on this filingEDGAR ↗
Dec 12, 2013 D
TriVascular Technologies, Inc.
File 021-207908
$0$0$0None listed on this filingEDGAR ↗
Nov 7, 2013 D
TriVascular Technologies, Inc.
File 021-205972
$0$0$0None listed on this filingEDGAR ↗
Jul 24, 2013 D
Cartiva, Inc.
File 021-200199
$0$0$0None listed on this filingEDGAR ↗
Dec 13, 2012 D
PATIENTKEEPER INC
File 021-188300
$232,500$0$0Trump Securities, LLC BrokerCheck CRD 47107 ↗EDGAR ↗
Nov 29, 2012 D
CV Ingenuity Corp.
File 021-187617
$0$0$0None listed on this filingEDGAR ↗
Nov 8, 2012 D
INTRINSIC THERAPEUTICS INC
File 021-186686
$0$0$0None listed on this filingEDGAR ↗
Nov 8, 2012 D
TriVascular Technologies, Inc.
File 021-186705
$0$680$0None listed on this filingEDGAR ↗
Jun 21, 2012 D/A
PATIENTKEEPER INC
File 021-180127
$0$0$0None listed on this filingEDGAR ↗
Jun 15, 2012 D
TriVascular Technologies, Inc.
File 021-179861
$0$0$0None listed on this filingEDGAR ↗
May 22, 2012 D
Vibrynt, INc
File 021-178652
$0$0$0None listed on this filingEDGAR ↗
May 9, 2012 D/A
New Enterprise Associates 14, L.P.
File 021-175533
$0$0$0 (est.)
An affiliate of the General Partner will receive a fee for management services. Amount to be paid, number of years to be paid and extent to be paid out of adjusted gross proceeds unknown at this time.
None listed on this filingEDGAR ↗
May 1, 2012 D
TriVascular Technologies, Inc.
File 021-177489
$0$0$0None listed on this filingEDGAR ↗
May 1, 2012 D
NEA 14 Manager Fund, L.P.
File 021-177519
$0$0$0None listed on this filingEDGAR ↗
Feb 7, 2012 D
TriVascular Technologies, Inc.
File 021-173009
$0$0$0None listed on this filingEDGAR ↗
Jan 17, 2012 D
Carticept Medical Inc
File 021-171945
$0$0$0None listed on this filingEDGAR ↗
Dec 22, 2011 D
PATIENTKEEPER INC
File 021-170556
$0$0$0None listed on this filingEDGAR ↗
Dec 5, 2011 D/A
Moximed, Inc
File 021-160894
$0$0$0None listed on this filingEDGAR ↗
Nov 25, 2011 D
ExploraMed IV, L.L.C.
File 021-169229
$0$0$0None listed on this filingEDGAR ↗
Oct 14, 2011 D/A
CV Ingenuity Corp.
File 021-166809
$0$0$0 (est.)None listed on this filingEDGAR ↗
Sep 26, 2011 D
PATIENTKEEPER INC
File 021-166341
$0$0$0None listed on this filingEDGAR ↗
May 16, 2011 D
Vibrynt, INc
File 021-159861
$0$0$0None listed on this filingEDGAR ↗
Feb 4, 2011 D
NEOTRACT INC
File 021-154828
$0$0$0None listed on this filingEDGAR ↗
Feb 3, 2011 D
SPINE WAVE, INC
File 021-154802
$0$0$0None listed on this filingEDGAR ↗
Nov 10, 2010 D/A
VIACOR INC
File 021-41429
$0$0$0None listed on this filingEDGAR ↗
Jul 15, 2010 D
TriVascular Technologies, Inc.
File 021-145049
$0$0$0None listed on this filingEDGAR ↗
Apr 2, 2010 D
SIMPLEX HEALTHCARE INC
File 021-123301
$0$0$0None listed on this filingEDGAR ↗
Mar 12, 2010 D
Carticept Medical Inc
File 021-82434
$0$0$0None listed on this filingEDGAR ↗
Feb 25, 2010 D
INTRINSIC THERAPEUTICS INC
File 021-51600
$0$0$0None listed on this filingEDGAR ↗
Feb 19, 2010 D/A
PATIENTKEEPER INC
File 021-66330
$0$0$0None listed on this filingEDGAR ↗
Oct 26, 2009 D/A
NEOTRACT INC
File 021-87399
$0$0$0None listed on this filingEDGAR ↗
Oct 16, 2009 D/A
NEW ENTERPRISE ASSOCIATES 13 LP
File 021-125476
$1,200,000 (est.)$0$0 (est.)
An affiliate of the General Partner will receive a fee for management services. Amount to be paid, number of years to be paid and extent to be paid out of adjusted gross proceeds unknown at this time.
Greenhill & Co., LLC BrokerCheck CRD 40290 ↗EDGAR ↗
Aug 14, 2009 D
Moximed, Inc
File 021-117353
$0$0$0None listed on this filingEDGAR ↗
May 27, 2009 D/A
OCEANA THERAPEUTICS, INC.
File 021-118709
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 38

Every issuer that named Ryan Drant on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

C
Other Health Care

Calyxo, Inc.

Pleasanton, CA · Oct 15, 2019 → Apr 16, 2026 · 5 filings
  • Apr 16, 2026 · D · $40,099,963 sold of $40,099,963 · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 26, 2024 · D · $28,275,528 sold of $31,999,998 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 3, 2023 · D · $50,000,000 sold of $50,000,000 · 16 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 2, 2022 · D · $22,693,900 sold of $22,693,900 · 18 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 15, 2019 · D · $12,863,376 sold of $15,863,376 · 20 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $50M from 50 investors (100% of the $40.1M target) as of the latest filing. Ryan is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AM
Other Health Care

Aerin Medical Inc.

Mountain View, CA · May 4, 2022 → Dec 30, 2024 · 2 filings
  • Dec 30, 2024 · D · $32,477,189 sold of $32,815,188 · 23 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 4, 2022 · D · $34,880,478 sold of $60,000,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $49.7M from 23 investors (100% of the $32.8M target) as of the latest filing. Ryan is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

C
Other Health Care

CORTICA INC.

San Diego, CA · Apr 25, 2023 → Nov 22, 2024 · 4 filings
  • Nov 22, 2024 · D · $80,999,998 sold of $80,999,998 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 2, 2023 · D/A · $114,716,314 sold of $114,716,314 · 21 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 25, 2023 · D · $15,227,043 sold of $17,537,009 · 34 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 25, 2023 · D · $75,666,318 sold of $89,216,329 · 16 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $114.7M from 34 investors (100% of the $81M target) as of the latest filing. Ryan is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

ES
Other Health Care

Eximis Surgical Inc.

Louisville, CO · Nov 8, 2018 → May 10, 2024 · 4 filings
  • May 10, 2024 · D/A · $15,344,314 sold of $16,242,615 · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 24, 2023 · D · $8,742,615 sold of $8,742,615 · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 28, 2020 · D/A · $16,999,994 sold of $18,499,993 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 8, 2018 · D · $7,500,000 sold of $16,000,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $17M from 29 investors (100% of the $16.2M target) as of the latest filing. Ryan is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AS
Other Health Care

Avive Solutions, Inc.

Brisbane, CA · Mar 11, 2022 → Apr 18, 2024 · 3 filings
  • Apr 18, 2024 · D/A · $56,708,189 sold of $56,708,189 · 114 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 14, 2024 · D · $40,858,434 sold of $51,708,207 · 105 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 11, 2022 · D · $35,870,527 sold of $35,870,527 · 142 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $56.7M from 142 investors (100% of the $56.7M target) as of the latest filing. Ryan is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

IT
Other Health Care

INTRINSIC THERAPEUTICS INC

Woburn, MA · Feb 25, 2010 → Dec 8, 2023 · 10 filings
  • Dec 8, 2023 · D · $55,489,287 sold of $68,489,279 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 18, 2023 · D · $5,501,901 sold of $5,501,901 · 18 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 13, 2023 · D · $5,914,800 sold of $7,500,000 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 7, 2021 · D · $38,444,385 sold of $40,000,000 · 13 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 23, 2019 · D · $38,785,331 sold of $41,669,207 · 28 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 21, 2017 · D/A · $28,432,510 sold of $28,432,510 · 22 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 16, 2016 · D · $17,877,087 sold of $20,156,585 · 18 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 17, 2014 · D · $17,256,239 sold of $20,878,287 · 28 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 8, 2012 · D · $11,662,297 sold of $12,250,000 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 25, 2010 · D · $18,000,251 sold of $20,000,002 · 11 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $55.5M from 28 investors (81% of the $68.5M target) as of the latest filing. Ryan is listed as director on 10 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

QC
Pooled Investment Fund · group: Questa

Questa Capital Partners III, L.P.

San Francisco, CA · Jun 14, 2022 → Jun 13, 2023 · 2 filings
  • Jun 13, 2023 · D/A · $396,565,000 sold of $396,565,000 · 67 investors · min. $50,000 · role: Executive Officer EDGAR ↗
  • Jun 14, 2022 · D · $0 sold of $400,000,000 · 0 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

Raised $396.6M from 67 investors (100% of the $396.6M target) as of the latest filing. Ryan is listed as executive officer on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

DH
Other Health Care

DispatchHealth Holdings, Inc.

Denver, CO · May 8, 2019 → Nov 28, 2022 · 4 filings
  • Nov 28, 2022 · D · $259,281,340 sold of $259,281,340 · 31 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 3, 2021 · D · $134,999,366 sold of $200,000,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 24, 2020 · D · $135,799,284 sold of $135,799,284 · 18 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 8, 2019 · D · $32,923,781 sold of $40,000,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $259.3M from 31 investors (100% of the $259.3M target) as of the latest filing. Ryan is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

QC
Pooled Investment Fund · group: Questa

Questa Capital Opportunities II, L.P.

San Francisco, CA · Jun 14, 2022
  • Jun 14, 2022 · D · $0 sold of $125,000,000 · 0 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

No sales reported yet as of the latest filing. Ryan is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

BH
Other Technology

Bicycle Health Inc.

Boston, MA · Jun 14, 2021 → May 23, 2022 · 2 filings
  • May 23, 2022 · D · $35,987,513 sold of $50,000,000 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 14, 2021 · D · $20,149,994 sold of $27,000,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $36M from 9 investors (72% of the $50M target) as of the latest filing. Ryan is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Technology / 506(b) (17,390 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

C
Other Health Care

ControlRad, Inc.

Peachtree Corners, GA · Oct 2, 2019 → Apr 11, 2022 · 3 filings
  • Apr 11, 2022 · D · $1,000,000 sold of $2,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 25, 2020 · D · $12,252,369 sold of $12,477,370 · 17 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 2, 2019 · D · $11,500,000 sold of $14,500,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $12.3M from 17 investors (100% of the $2M target) as of the latest filing. Ryan is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

QC
Pooled Investment Fund · group: Questa

Questa Capital Opportunities I, L.P.

San Francisco, CA · Mar 25, 2021
  • Mar 25, 2021 · D · $82,850,000 sold of $82,850,000 · 44 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

Raised $82.8M from 44 investors (100% of the $82.8M target) as of the latest filing. Ryan is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

QC
Pooled Investment Fund · group: Questa

Questa Capital Partners II, L.P.

San Francisco, CA · Jan 22, 2020 → Aug 21, 2020 · 2 filings
  • Aug 21, 2020 · D/A · $304,850,000 sold of $338,000,000 · 59 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Jan 22, 2020 · D · $0 sold of $300,000,000 · 0 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

Raised $304.9M from 59 investors (90% of the $338M target) as of the latest filing. Ryan is listed as executive officer on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

ST
Other Health Care

Solace Therapeutics Inc

Framingham, MA · Sep 6, 2016 → Feb 11, 2019 · 2 filings
  • Feb 11, 2019 · D · $1,900,000 sold of $2,114,965 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 6, 2016 · D · $13,000,000 sold of $20,000,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $13M from 8 investors (100% of the $2.11M target) as of the latest filing. Ryan is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

S
Other Technology

SyncHR, Inc.

Denver, CO · Oct 13, 2015 → Oct 19, 2018 · 4 filings
  • Oct 19, 2018 · D · $11,981,496 sold of $15,402,722 · 40 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 21, 2018 · D · $5,159,607 sold of $6,000,000 · 21 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 3, 2017 · D · $13,040,985 sold of $19,999,993 · 26 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 13, 2015 · D · $16,038,668 sold of $16,352,418 · 39 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $16M from 40 investors (100% of the $15.4M target) as of the latest filing. Ryan is listed as director, executive officer on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Technology / 506(b) (17,390 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SW
Other Health Care

SPINE WAVE, INC

Shelton, CT · Feb 3, 2011 → Jul 27, 2018 · 3 filings
  • Jul 27, 2018 · D · $5,300,498 sold of $5,500,000 · 29 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 31, 2016 · D · $4,400,000 sold of $11,100,000 · 30 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 3, 2011 · D · $17,649,719 sold of $17,649,719 · 28 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $17.6M from 30 investors (100% of the $5.5M target) as of the latest filing. Ryan is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

QC
Pooled Investment Fund · group: Questa

Questa Capital Partners I, L.P.

San Francisco, CA · Oct 21, 2016 → Sep 15, 2017 · 2 filings
  • Sep 15, 2017 · D/A · $99,747,475 sold of $250,000,000 · 10 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Oct 21, 2016 · D · $0 sold of $250,000,000 · 0 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

Raised $99.7M from 10 investors (40% of the $250M target) as of the latest filing. Ryan is listed as executive officer on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

M
Other

Medrio, Inc.

San Francisco, CA · May 26, 2017
  • May 26, 2017 · D · $24,999,997 sold of $29,999,999 · 2 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $25M from 33 investors (83% of the $30M target) as of the latest filing. Ryan is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

EC
Other Health Care

Earlens Corp

Menlo Park, CA · Jun 15, 2016 → May 25, 2017 · 2 filings
  • May 25, 2017 · D/A · $72,121,791 sold of $77,274,197 · 59 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 15, 2016 · D · $53,593,010 sold of $69,029,068 · 22 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $72.1M from 147 investors (93% of the $77.3M target) as of the latest filing. Ryan is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

RP
Other Health Care

Radiology Partners Holdings, LLC

Nashville, TN · May 22, 2014 → May 16, 2017 · 3 filings
  • May 16, 2017 · D · $200,021,140 sold of $200,021,140 · 56 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 11, 2017 · D · $1,795,200 sold of $1,795,200 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 22, 2014 · D · $476,680 sold of $800,000 · 15 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $719.8M from 645 investors (100% of the $200M target) as of the latest filing. Ryan is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AC
Other Health Care

ADVANCED CARDIAC THERAPEUTICS INC

Santa Clara, CA · May 8, 2017
  • May 8, 2017 · D · $44,999,998 sold of $45,999,997 · 4 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $45M from 26 investors (98% of the $46M target) as of the latest filing. Ryan is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

M
Other Health Care · group: Med Tech Arbitrage

Moximed, Inc

Fremont, CA · Aug 14, 2009 → Mar 31, 2017 · 5 filings
  • Mar 31, 2017 · D · $49,541,720 sold of $51,450,000 · 8 investors · min. $1 · role: Director EDGAR ↗
  • May 5, 2015 · D · $19,742,755 sold of $37,642,028 · 104 investors · min. $1 · role: Director EDGAR ↗
  • Dec 5, 2011 · D/A · $45,837,656 sold of $45,862,892 · 55 investors · min. $1 · role: Director EDGAR ↗
  • Jun 7, 2011 · D · $43,269,656 sold of $45,300,000 · 6 investors · min. $2 · role: Director EDGAR ↗
  • Aug 14, 2009 · D · $10,000,000 sold of $11,000,000 · 2 investors · min. $2 · role: Director EDGAR ↗

Raised $62.7M from 104 investors (100% of the $51.5M target) as of the latest filing. Ryan is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

N
Other Health Care

NEOTRACT INC

Pleasanton, CA · Jul 28, 2009 → Jan 6, 2017 · 6 filings
  • Jan 6, 2017 · D · $12,816,967 sold of $14,999,999 · 12 investors · min. $1 · role: Director EDGAR ↗
  • Jan 28, 2014 · D/A · $50,556,684 sold of $56,700,000 · 71 investors · min. $1 · role: Director EDGAR ↗
  • May 24, 2012 · D · $32,399,995 sold of $40,320,000 · 12 investors · min. $1 · role: Director EDGAR ↗
  • Feb 4, 2011 · D · $25,999,999 sold of $27,331,840 · 5 investors · min. $1 · role: Director EDGAR ↗
  • Oct 26, 2009 · D/A · $28,108,160 sold of $30,240,000 · 15 investors · min. $1 · role: Director EDGAR ↗
  • Jul 28, 2009 · D · $23,733,044 sold of $25,200,000 · 3 investors · min. $1 · role: Director EDGAR ↗

Raised $50.6M from 71 investors (100% of the $15M target) as of the latest filing. Ryan is listed as director on 6 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

C
Other Health Care · group: Carticept

Cartiva, Inc.

Alpharetta, GA · Jul 24, 2013 → Nov 18, 2016 · 4 filings
  • Nov 18, 2016 · D · $7,000,000 sold of $8,500,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 17, 2015 · D · $6,000,001 sold of $8,500,001 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 29, 2014 · D · $1,500,000 sold of $1,500,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 24, 2013 · D · $4,312,712 sold of $4,482,240 · 9 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $7M from 9 investors (82% of the $8.5M target) as of the latest filing. Ryan is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

TT
Other Health Care

TriVascular Technologies, Inc.

Santa Rosa, CA · Jul 15, 2010 → Aug 21, 2015 · 8 filings
  • Aug 21, 2015 · D · $10,000,000 sold of $10,000,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 12, 2013 · D · $1,950,270 sold of $1,950,270 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 7, 2013 · D · $39,643,841 sold of $40,000,000 · 23 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 8, 2012 · D · $68,000 sold of $68,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 15, 2012 · D · $35,421,757 sold of $60,388,000 · 34 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 1, 2012 · D · $4,000,001 sold of $4,000,001 · 22 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 7, 2012 · D · $7,161,013 sold of $7,200,000 · 22 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 15, 2010 · D · $45,000,000 sold of $45,000,000 · 18 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $45M from 34 investors (100% of the $10M target) as of the latest filing. Ryan is listed as director on 8 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

N
Other Health Care

Nuelle, Inc.

Mountain View, CA · Jan 21, 2014 → Apr 20, 2015 · 3 filings
  • Apr 20, 2015 · D · $7,050,358 sold of $7,500,000 · 4 investors · min. $1 · role: Director EDGAR ↗
  • Jul 8, 2014 · D/A · $15,536,290 sold of $15,536,290 · 28 investors · min. $1 · role: Director EDGAR ↗
  • Jan 21, 2014 · D · $13,999,998 sold of $14,999,999 · 4 investors · min. $1 · role: Director EDGAR ↗

Raised $15.5M from 28 investors (100% of the $7.5M target) as of the latest filing. Ryan is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

WI
Other Health Care

Willow Innovations, Inc.

Mountain View, CA · Jan 21, 2015 → Mar 9, 2015 · 2 filings
  • Mar 9, 2015 · D/A · $17,410,000 sold of $17,500,000 · 43 investors · min. $1 · role: Director EDGAR ↗
  • Jan 21, 2015 · D · $15,000,000 sold of $16,000,000 · 5 investors · min. $1 · role: Director EDGAR ↗

Raised $81.4M from 43 investors (100% of the $17.5M target) as of the latest filing. Ryan is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

P
Other Health Care

PATIENTKEEPER INC

Waltham, MA · Dec 22, 2009 → Dec 13, 2012 · 7 filings
  • Dec 13, 2012 · D · $900,000 sold of $1,080,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 21, 2012 · D/A · $1,973,215 sold of $6,250,000 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 21, 2012 · D · $1,973,215 sold of $6,250,000 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 22, 2011 · D · $558,653 sold of $3,000,000 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 26, 2011 · D · $1,500,000 sold of $3,000,000 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 19, 2010 · D/A · $8,275,005 sold of $8,275,005 · 0 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 22, 2009 · D · $8,000,004 sold of $8,000,004 · 0 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $8.28M from 10 investors (100% of the $1.08M target) as of the latest filing. Ryan is listed as director on 7 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

CI
Biotechnology

CV Ingenuity Corp.

Fremont, CA · Oct 5, 2011 → Nov 29, 2012 · 3 filings
  • Nov 29, 2012 · D · $11,136,154 sold of $11,136,154 · 25 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 14, 2011 · D/A · $17,383,237 sold of $18,011,243 · 23 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 5, 2011 · D · $16,011,243 sold of $18,011,243 · 19 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $17.4M from 25 investors (100% of the $11.1M target) as of the latest filing. Ryan is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

V
Other Health Care

Vibrynt, INc

Redwood City, CA · May 16, 2011 → May 22, 2012 · 2 filings
  • May 22, 2012 · D · $2,750,000 sold of $5,500,000 · 5 investors · min. $1 · role: Director EDGAR ↗
  • May 16, 2011 · D · $11,500,000 sold of $11,500,000 · 5 investors · min. $1 · role: Director EDGAR ↗

Raised $11.5M from 5 investors (100% of the $5.5M target) as of the latest filing. Ryan is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

NE
Pooled Investment Fund · group: Nea

New Enterprise Associates 14, L.P.

Timonium, MD · Mar 26, 2012 → May 9, 2012 · 2 filings
  • May 9, 2012 · D/A · $2,075,859,276 sold of $2,562,940,000 · 146 investors · min. No minimum reported · role: Director (Director of the GP LTD) EDGAR ↗
  • Mar 26, 2012 · D · $0 sold of $2,300,000,000 · 0 investors · min. No minimum reported · role: Director (Director of the GP LTD) EDGAR ↗

Raised $2.08B from 146 investors (81% of the $2.56B target) as of the latest filing. Ryan is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

N1
Pooled Investment Fund · group: Nea

NEA 14 Manager Fund, L.P.

Timonium, MD · May 1, 2012
  • May 1, 2012 · D · $0 sold of $12,877,500 · 0 investors · min. No minimum reported · role: Director (Director of the GP LTD) EDGAR ↗

No sales reported yet as of the latest filing. Ryan is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

CM
Other Health Care · group: Carticept

Carticept Medical Inc

Alpharetta, GA · Mar 12, 2010 → Jan 17, 2012 · 2 filings
  • Jan 17, 2012 · D · $9,566,312 sold of $10,000,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 12, 2010 · D · $10,000,001 sold of $20,000,002 · 0 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $10M from 3 investors (100% of the $10M target) as of the latest filing. Ryan is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

EL
Other · group: Exploramed

ExploraMed IV, L.L.C.

Mountain View, CA · Nov 25, 2011
  • Nov 25, 2011 · D · $6,600,000 sold of $8,000,000 · 1 investors · min. $1 · role: Director EDGAR ↗

Raised $6.6M from 1 investor (83% of the $8M target) as of the latest filing. Ryan is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

V
Other Health Care

VIACOR INC

Wilmington, MA · Apr 22, 2009 → Nov 10, 2010 · 7 filings
  • Nov 10, 2010 · D/A · $8,884,916 sold of $9,584,916 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 12, 2010 · D/A · $8,084,916 sold of $8,084,916 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 7, 2010 · D · $1,924,755 sold of $1,924,755 · 0 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 7, 2010 · D/A · $6,584,916 sold of $6,584,916 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 15, 2009 · D · $2,410,222 sold of $2,410,222 · 0 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 21, 2009 · D/A · $3,050,949 sold of $5,084,916 · 0 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 22, 2009 · D · $3,000,000 sold of $5,000,000 · 0 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $8.88M from 7 investors (93% of the $9.58M target) as of the latest filing. Ryan is listed as director on 7 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

SH
Other Health Care

SIMPLEX HEALTHCARE INC

Franklin, TN · Apr 2, 2010
  • Apr 2, 2010 · D · $2,999,997 sold of $4,999,999 · 9 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $3M from 9 investors (60% of the $5M target) as of the latest filing. Ryan is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

NE
Pooled Investment Fund · group: Nea

NEW ENTERPRISE ASSOCIATES 13 LP

Baltimore, MD · Apr 27, 2009 → Oct 16, 2009 · 2 filings
  • Oct 16, 2009 · D/A · $2,457,680,000 sold of $2,500,000,000 · 187 investors · min. No minimum reported · role: Director (Director of the GP LTD) EDGAR ↗
  • Apr 27, 2009 · D/A · $2,152,425,000 sold of $2,500,000,000 · 160 investors · min. No minimum reported · role: Director (Director of the GP LTD) EDGAR ↗

Raised $2.46B from 187 investors (98% of the $2.5B target) as of the latest filing. Ryan is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

OT
Pharmaceuticals

OCEANA THERAPEUTICS, INC.

Mendham, NJ · May 27, 2009
  • May 27, 2009 · D/A · $3,000,000 sold of $50,000,001 · 4 investors · min. $16,770 · role: Director EDGAR ↗

Raised $3M from 4 investors (6% of the $50M target) as of the latest filing. Ryan is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

People around Ryan 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

N1
Management entity

NEA 14 GP, LTD

Executive Officer · 3 shared filings (2 issuers)

Listed on the same filings as Ryan Drant. Their page shows their other deals.

NP
Management entity

NEA Partners 14, L.P.

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Ryan Drant. Their page shows their other deals.

JM
No photo found yet (own website and image search run after this page is viewed)
Person

Joshua Makower

Director, Executive Officer · 25 shared filings (7 issuers) · also on 9 other issuers

Joshua Makower is on 16 issuers in total — a repeat sponsor. Their page lists every one.

RC
No photo found yet (own website and image search run after this page is viewed)
Person

Robert W. Croce

Director · 18 shared filings (6 issuers) · also on 6 other issuers

Robert W. Croce is on 12 issuers in total — a repeat sponsor. Their page lists every one.

GL
No photo found yet (own website and image search run after this page is viewed)
Person

Gregory Lambrecht

Director, Executive Officer · 17 shared filings (2 issuers)

Listed on the same filings as Ryan Drant. Their page shows their other deals.

JN
No photo found yet (own website and image search run after this page is viewed)
Person

John Nehra

Director · 13 shared filings (5 issuers) · also on 11 other issuers

John Nehra is on 16 issuers in total — a repeat sponsor. Their page lists every one.

RM
No photo found yet (own website and image search run after this page is viewed)
Person

Robert More

Director · 13 shared filings (5 issuers) · also on 10 other issuers

Robert More is on 15 issuers in total — a repeat sponsor. Their page lists every one.

KS
No photo found yet (own website and image search run after this page is viewed)
Person

Kevin Sidow

Executive Officer, Director · 12 shared filings (2 issuers) · also on 5 other issuers

Kevin Sidow is on 7 issuers in total — a repeat sponsor. Their page lists every one.

RT
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Thomas

Director, Executive Officer · 11 shared filings (2 issuers) · also on 3 other issuers

Robert Thomas is on 5 issuers in total — a repeat sponsor. Their page lists every one.

DR
No photo found yet (own website and image search run after this page is viewed)
Person

Douglas Roeder

Director · 10 shared filings (2 issuers) · also on 3 other issuers

Douglas Roeder is on 5 issuers in total — a repeat sponsor. Their page lists every one.

TL
No photo found yet (own website and image search run after this page is viewed)
Person

Theodore Lamson

Executive Officer, Director · 10 shared filings (2 issuers)

Listed on the same filings as Ryan Drant. Their page shows their other deals.

RA
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Anderson

Director · 9 shared filings (5 issuers) · also on 12 other issuers

Robert Anderson is on 17 issuers in total — a repeat sponsor. Their page lists every one.

MK
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Kramer

Executive Officer · 9 shared filings (2 issuers) · also on 12 other issuers

Michael Kramer is on 14 issuers in total — a repeat sponsor. Their page lists every one.

JN
No photo found yet (own website and image search run after this page is viewed)
Person

Jake Nunn

Director · 8 shared filings (1 issuer) · also on 4 other issuers

Jake Nunn is on 5 issuers in total — a repeat sponsor. Their page lists every one.

PP
No photo found yet (own website and image search run after this page is viewed)
Person

Peter J. Pizzo

Executive Officer · 8 shared filings (3 issuers) · also on 1 other issuer

Listed on the same filings as Ryan Drant. Their page shows their other deals.

JD
No photo found yet (own website and image search run after this page is viewed)
Person

Jeani Delagardelle

Director · 8 shared filings (1 issuer)

Listed on the same filings as Ryan Drant. Their page shows their other deals.

CH
No photo found yet (own website and image search run after this page is viewed)
Person

Cary Hagan

Executive Officer, Director · 8 shared filings (1 issuer)

Listed on the same filings as Ryan Drant. Their page shows their other deals.

KC
No photo found yet (own website and image search run after this page is viewed)
Person

Kevin Connors

Director, Executive Officer · 8 shared filings (2 issuers) · also on 4 other issuers

Kevin Connors is on 6 issuers in total — a repeat sponsor. Their page lists every one.

HS
No photo found yet (own website and image search run after this page is viewed)
Person

H. Bradley Sloan

Executive Officer · 7 shared filings (5 issuers) · also on 3 other issuers

H. Bradley Sloan is on 8 issuers in total — a repeat sponsor. Their page lists every one.

CH
No photo found yet (own website and image search run after this page is viewed)
Person

Charles M. Hazard, Jr.

Director · 7 shared filings (1 issuer) · also on 23 other issuers

Charles M. Hazard, Jr. is on 24 issuers in total — a repeat sponsor. Their page lists every one.

RS
No photo found yet (own website and image search run after this page is viewed)
Person

Richard Spencer, III

Executive Officer, Director · 7 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Ryan Drant. Their page shows their other deals.

SS
No photo found yet (own website and image search run after this page is viewed)
Person

Sean Salmon

Director · 7 shared filings (1 issuer)

Listed on the same filings as Ryan Drant. Their page shows their other deals.

JR
No photo found yet (own website and image search run after this page is viewed)
Person

Jonathan Rourke

Executive Officer, Director · 7 shared filings (1 issuer)

Listed on the same filings as Ryan Drant. Their page shows their other deals.

CH
No photo found yet (own website and image search run after this page is viewed)
Person

Chris Hutchins

Executive Officer · 7 shared filings (1 issuer)

Listed on the same filings as Ryan Drant. Their page shows their other deals.

HP
No photo found yet (own website and image search run after this page is viewed)
Person

Henry A. Plain, Jr.

Director · 7 shared filings (2 issuers) · also on 12 other issuers

Henry A. Plain, Jr. is on 14 issuers in total — a repeat sponsor. Their page lists every one.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

James Shapiro

Director · 7 shared filings (1 issuer) · also on 5 other issuers

James Shapiro is on 6 issuers in total — a repeat sponsor. Their page lists every one.

LM
No photo found yet (own website and image search run after this page is viewed)
Person

Larry Miller, MD

Director · 7 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Ryan Drant. Their page shows their other deals.

MM
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Merson

Director · 7 shared filings (1 issuer)

Listed on the same filings as Ryan Drant. Their page shows their other deals.

PB
No photo found yet (own website and image search run after this page is viewed)
Person

Paul Brient

Executive Officer, Director · 7 shared filings (1 issuer)

Listed on the same filings as Ryan Drant. Their page shows their other deals.

RS
No photo found yet (own website and image search run after this page is viewed)
Person

Ralph Sabin

Director · 7 shared filings (1 issuer)

Listed on the same filings as Ryan Drant. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

James Scopa

Director · 7 shared filings (1 issuer) · also on 6 other issuers

James Scopa is on 7 issuers in total — a repeat sponsor. Their page lists every one.

CB
No photo found yet (own website and image search run after this page is viewed)
Person

Coy Blevins

Director · 7 shared filings (1 issuer)

Listed on the same filings as Ryan Drant. Their page shows their other deals.

JK
No photo found yet (own website and image search run after this page is viewed)
Person

Justin Klein

Director · 7 shared filings (3 issuers) · also on 4 other issuers

Justin Klein is on 7 issuers in total — a repeat sponsor. Their page lists every one.

WF
No photo found yet (own website and image search run after this page is viewed)
Person

William Facteau

Director, Executive Officer · 7 shared filings (3 issuers) · also on 2 other issuers

William Facteau is on 5 issuers in total — a repeat sponsor. Their page lists every one.

The team behind the deals

Q
Sponsor group

Questa

5 issuers · 8 filings · $884M reported sold · 2016–2023

One team, 5 deal companies. Ryan Drant is listed on 5 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Ryan Drant.

N
Sponsor group

Nea

19 issuers · 27 filings · $10.96B reported sold · 2009–2025

One team, 19 deal companies. Ryan Drant is listed on 3 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Ryan Drant.

C
Sponsor group

Carticept

2 issuers · 6 filings · $16.6M reported sold · 2010–2016

One team, 2 deal companies. Ryan Drant is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Ryan Drant.

E
Sponsor group

Exploramed

3 issuers · 4 filings · $65.4M reported sold · 2011–2021

One team, 3 deal companies. Ryan Drant is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Ryan Drant.

MT
Sponsor group

Med Tech Arbitrage

6 issuers · 13 filings · $67.5M reported sold · 2009–2026

One team, 6 deal companies. Ryan Drant is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Ryan Drant.

Same business address

51 other issuers file from the same address (first 50 shown)

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

None of the 38 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Ryan Drant by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 38 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Ryan Drant is listed on: none on file. No website or social profile named in NEW ENTERPRISE ASSOCIATES 13 LP's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #367,262 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Baltimore, MD). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗Maryland Judiciary case search ↗California — find the county court ↗Los Angeles Superior Court case search ↗Massachusetts MassCourts ↗Davidson County TN Circuit Court Clerk case search ↗Georgia state courts — find the court ↗Colorado state courts — find the court ↗Connecticut Judicial Branch case look-up ↗New Jersey state courts — find the court ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

Maryland Secretary of State business search ↗California Secretary of State business search ↗Massachusetts Secretary of State business search ↗Tennessee Secretary of State business search ↗Georgia Secretary of State business search ↗Colorado Secretary of State business search ↗Connecticut Secretary of State business search ↗New Jersey Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Ryan Drant appears on a new Form D, or when a court case or SEC action is matched to them. See plans →